Curis, Inc. (Nasdaq: CRIS), an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE